Craig Gracey Sells 637 Shares of Omada Health (NASDAQ:OMDA) Stock

Omada Health, Inc. (NASDAQ:OMDA) CAO Craig Gracey sold 637 shares of the company’s stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $23.00, for a total value of $14,651.00. Following the completion of the transaction, the chief accounting officer directly owned 15,441 shares of the company’s stock, valued at $355,143. This trade represents a 3.96% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Craig Gracey also recently made the following trade(s):

• On Tuesday, June 30th, Craig Gracey sold 405 shares of Omada Health stock. The stock was sold at an average price of $22.00, for a total transaction of $8,910.00.
• On Monday, June 29th, Craig Gracey sold 2,083 shares of Omada Health stock. The shares were sold at an average price of $21.00, for a total transaction of $43,743.00.
• On Friday, June 26th, Craig Gracey sold 2,084 shares of Omada Health stock. The shares were sold at an average price of $20.00, for a total transaction of $41,680.00.
• On Wednesday, June 24th, Craig Gracey sold 2,083 shares of Omada Health stock. The shares were sold at an average price of $19.01, for a total transaction of $39,597.83.
• On Monday, June 22nd, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $18.00, for a total value of $37,494.00.
• On Friday, June 12th, Craig Gracey sold 6,894 shares of Omada Health stock. The shares were sold at an average price of $17.42, for a total value of $120,093.48.

Omada Health Stock Down 1.0%

Shares of NASDAQ OMDA traded down $0.23 during trading hours on Thursday, reaching $22.39. The stock had a trading volume of 835,372 shares, compared to its average volume of 1,067,190. The firm has a 50-day moving average of $17.16 and a 200-day moving average of $15.03. Omada Health, Inc. has a fifty-two week low of $10.28 and a fifty-two week high of $26.92.

Omada Health (NASDAQ:OMDA) last issued its quarterly earnings data on Thursday, May 7th. The company reported ($0.05) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.08) by $0.03. The company had revenue of $78.05 million during the quarter. Omada Health had a negative return on equity of 1.82% and a negative net margin of 2.22%. Equities research analysts forecast that Omada Health, Inc. will post -0.01 earnings per share for the current year.

Institutional Investors Weigh In On Omada Health

Hedge funds have recently made changes to their positions in the business. Raymond James Financial Inc. acquired a new position in Omada Health in the second quarter valued at $32,000. Quarry LP purchased a new stake in Omada Health in the fourth quarter valued at approximately $29,000. TD Waterhouse Canada Inc. acquired a new position in Omada Health during the fourth quarter worth approximately $32,000. Inlight Wealth Management LLC purchased a new position in Omada Health during the fourth quarter worth approximately $45,000. Finally, Versant Capital Management Inc boosted its holdings in shares of Omada Health by 319.3% in the 2nd quarter. Versant Capital Management Inc now owns 2,998 shares of the company’s stock valued at $66,000 after purchasing an additional 2,283 shares during the last quarter.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on OMDA shares. BMO Capital Markets lowered their price objective on shares of Omada Health from $27.00 to $18.00 and set an “outperform” rating on the stock in a research report on Friday, March 6th. Canaccord Genuity Group set a $24.00 price objective on shares of Omada Health in a research report on Friday, May 8th. Needham & Company LLC reiterated a “buy” rating and issued a $28.00 price target on shares of Omada Health in a research report on Friday, May 8th. Barclays upped their target price on Omada Health from $18.00 to $20.00 and gave the company an “overweight” rating in a research note on Friday, May 8th. Finally, Evercore restated an “outperform” rating and issued a $20.00 price objective on shares of Omada Health in a research report on Friday, May 8th. Ten equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $22.91.

About Omada Health

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.